Evidence map›Paper›PMID 26106831›Full record

ArticleAnnals of surgery2016

Ketorolac Use and Postoperative Complications in Gastrointestinal Surgery.

Meera Kotagal, Timo W Hakkarainen, Vlad V Simianu, Sara J Beck, Rafael Alfonso-Cristancho, David R Flum

Open access · greenAbstract readClinical Study
In one paragraph

Article in Annals of surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Anastomotic Leak Following Colorectal Surgery.Clinics in colon and rectal surgery · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. NSAIDs, are they dangerous for pancreatic surgery?Korean journal of anesthesiology · 2022
    Article
  9. The Impact of Preoperative Anti-TNFα Therapy on Postoperative Outcomes Following Ileocolectomy in Crohn's Disease.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2021
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Risk of anastomotic leakage with nonsteroidal anti-inflammatory drugs within an enhanced recovery program.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Meera Kotagal*Department of Surgery, University of Washington, Surgical Outcomes Research Center (SORCE), CHASE Alliance, Seattle, WA †Surgical Outcomes Research Center (SORCE), University of Washington, Seattle, WA 98105.
Timo W Hakkarainen
Vlad V Simianu
Sara J Beck
Rafael Alfonso-Cristancho
David R Flum
University of Washington · USWashington Center · US

Funding

Renewal: Gastrointestinal Surgery Outcomes Research FellowshipT32DK070555 · NIDDK · UNIVERSITY OF WASHINGTON · PI FLUM, DAVID R · 2010 to 2024
$3.6M
NIDDK NIH HHS T32 DK070555NIDDK NIH HHS T32DK070555
6 · The paper itself

Abstract

objectiveTo study the association between ketorolac use and postoperative complications.

backgroundNonsteroidal anti-inflammatory drugs may impair wound healing and increase the risk of anastomotic leak in colon surgery. Studies to date have been limited by sample size, inability to identify confounding, and a focus limited to colon surgery.

methodsKetorolac use, reinterventions, emergency department (ED) visits, and readmissions in adults (≥ 18 years) undergoing gastrointestinal (GI) operations was assessed in a nationwide cohort using the MarketScan Database (2008-2012).

resultsAmong 398,752 patients (median age 52, 45% male), 55% underwent colorectal surgery, whereas 45% had noncolorectal GI surgery. Five percent of patients received ketorolac. Adjusting for demographic characteristics, comorbidities, surgery type/indication, and preoperative medications, patients receiving ketorolac had higher odds of reintervention (odds ratio [OR] 1.20, 95% confidence interval [CI] 1.08-1.32), ED visit (OR 1.44, 95% CI 1.37-1.51), and readmission within 30 days (OR 1.11, 95% CI 1.05-1.18) compared to those who did not receive ketorolac. Ketorolac use was associated with readmissions related to anastomotic complications (OR 1.20, 95% CI 1.06-1.36). Evaluating only admissions with ≤ 3 days duration to exclude cases where ketorolac might have been used for complication-related pain relief, the odds of complications associated with ketorolac were even greater.

conclusionsUse of intravenous ketorolac was associated with greater odds of reintervention, ED visit, and readmission in both colorectal and noncolorectal GI surgery. Given this confirmatory evaluation of other reports of a negative association and the large size of this cohort, clinicians should exercise caution when using ketorolac in patients undergoing GI surgery.

Indexed as

Digestive System Surgical ProceduresAnti-Inflammatory Agents, Non-SteroidalEmergenciesFemaleHumansKetorolacMaleMiddle AgedPatient ReadmissionPostoperative ComplicationsReoperationRetrospective StudiesAnti-Inflammatory Agents, Non-SteroidalKetorolac

Identifiers

PMID26106831
PMCPMC4684464
OpenAlexW2282040364

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.